EDGAR Filing Documents for 0001600132-21-000048

Form 8-K - Current report:

SEC Accession No. 0001600132-21-000048

Filing Date

2021-10-12

Accepted

2021-10-12 16:59:25

Documents

Period of Report

2021-10-07

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	blph-20211007x8k.htm iXBRL	8-K	40822
	Complete submission text file	0001600132-21-000048.txt		157238

Data Files

Seq	Description	Document	Type	Size
2	EX-101.SCH	blph-20211007.xsd	EX-101.SCH	3165
3	EX-101.LAB	blph-20211007_lab.xml	EX-101.LAB	15274
4	EX-101.PRE	blph-20211007_pre.xml	EX-101.PRE	9676
5	EXTRACTED XBRL INSTANCE DOCUMENT	blph-20211007x8k_htm.xml	XML	4688

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059

Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770

Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)